Pharmaceutical Industry News

"There is an increasing demand for HPAPIs due to their effectiveness against cancer at lower doses and the trend towards more targeted therapeutics.

Qosina, a global supplier of OEM single-use components to the medical and biopharmaceutical industries, is pleased to introduce the MicroCNX™ Series to its line of genderless aseptic connectors.

Bruker Corporation (Nasdaq: BRKR) extends the power of mass spectrometry inside and outside the laboratory to Point-of-Need (PoN) analysis with the introduction of the DART-EVOQ® triple quadrupole mass spectrometer for high-throughput quantitative analyses.

Immunicom, Inc., a privately held clinical-stage biotechnology company with a transformative immuno-oncology platform, presented data from its ongoing clinical investigation [NCT04004910] at the Annual Meeting.

The drug, called VV116, is a derivative of Gilead Sciences's COVID drug Remdesivir and was approved for use in moderate-to-severe cases in Uzbekistan last year.

Journal of Endovascular Therapy, 2022 (Impact factor 3.487 source Sage Journals) with title "Stents with torsional strength for Superficial Femoral artery disease. The prospective Q3-Registry" by Thieme et al.

This report studies the Chemistry Laboratory Robots Market with many aspects of the industry like the market size, market status, market trends and forecast.

Recent studies about the reduction in narcotics or antibiotics prescriptions for postoperative pain management and care have indicated success in the urologic field.

Do socioeconomic disparities impact a bladder cancer patient's care?  Can exercise improve the health of bladder cancer patients during treatment? What technologic and pharmacologic advances are urologists utilizing to treat bladder cancer?

The US Food and Drug Administration (FDA) granted approval to oral edaravone (RADICAVA ORS) for the treatment of amyotrophic lateral sclerosis (ALS).